<< Oestrogen research points to new class of analgesic drugs | New avenues for the treatment of amblyopia >>
Read in | English | Nederlands | Ελληνικά | Bahasa

Metabolic cell activity directly controls life and death decisions in cells

Published on August 13, 2007 at 11:05 PM · No Comments

Researchers at the University of Pennsylvania School of Medicine have found that proteins known to promote cell death are also necessary for the maturation and proliferation of immune cells.

Activation of T-cell receptors on the surface of lymphocytes by foreign antigens initiate a calcium-mediated signaling pathway that ends in cell differentiation and growth. The Penn scientists discovered that in the cells that lack the pro-death proteins Bax and Bak, calcium signaling is disrupted and energy production is reduced. Restoration of Bax corrects the signaling problems, increases energy production, and stimulates cell division.

The results, published online in the journal Immunity, bolster the team's hypothesis that metabolic cell activity directly controls life and death decisions in cells. This issue also includes a related commentary by the study's lead author, Russell Jones, PhD, and senior author Craig B. Thompson, MD.

It is well known that cells that lack Bax (Bcl-2-associated X protein) and Bak (Bcl-2-antagonist/killer) continue living under conditions that would cause normal cells to undergo programmed cell death or apoptosis. What is less well understood, is why lymphocytes missing these key proteins are unable to trigger a strong immune response and do not proliferate as normal in response to stimulation.

"We simply say they are the same thing," says Thompson, Director of the Abramson Cancer Center and Chairman and Professor of Cancer Biology and Medicine. "The molecular basis of both findings is based on how Bax and Bak work on intracellular membranes."

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading